Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Survival rates and prognostic predictors of high grade brain stem gliomas in childhood: a systematic review and meta-analysis.

Hassan H, Pinches A, Picton SV, Phillips RS.

J Neurooncol. 2017 Oct;135(1):13-20. doi: 10.1007/s11060-017-2546-1. Epub 2017 Jul 5. Review.

2.

Pediatric high-grade gliomas and diffuse intrinsic pontine gliomas.

Fangusaro J.

J Child Neurol. 2009 Nov;24(11):1409-17. doi: 10.1177/0883073809338960. Epub 2009 Jul 28. Review.

PMID:
19638636
3.

A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.

Hummel TR, Salloum R, Drissi R, Kumar S, Sobo M, Goldman S, Pai A, Leach J, Lane A, Pruitt D, Sutton M, Chow LM, Grimme L, Doughman R, Backus L, Miles L, Stevenson C, Fouladi M, DeWire M.

J Neurooncol. 2016 Mar;127(1):53-61. doi: 10.1007/s11060-015-2008-6. Epub 2015 Dec 1.

PMID:
26626490
4.

Retrospective analysis of 104 histologically proven adult brainstem gliomas: clinical symptoms, therapeutic approaches and prognostic factors.

Reithmeier T, Kuzeawu A, Hentschel B, Loeffler M, Trippel M, Nikkhah G.

BMC Cancer. 2014 Feb 21;14:115. doi: 10.1186/1471-2407-14-115.

5.

Diffusion-weighted MRI derived apparent diffusion coefficient identifies prognostically distinct subgroups of pediatric diffuse intrinsic pontine glioma.

Lober RM, Cho YJ, Tang Y, Barnes PD, Edwards MS, Vogel H, Fisher PG, Monje M, Yeom KW.

J Neurooncol. 2014 Mar;117(1):175-82. doi: 10.1007/s11060-014-1375-8. Epub 2014 Feb 13.

PMID:
24522717
6.

Re-Examining the Need for Tissue Diagnosis in Pediatric Diffuse Intrinsic Pontine Gliomas: A Review.

Infinger LK, Stevenson CB.

Curr Neuropharmacol. 2017;15(1):129-133. Review.

7.

Brainstem gliomas in adults: prognostic factors and classification.

Guillamo JS, Monjour A, Taillandier L, Devaux B, Varlet P, Haie-Meder C, Defer GL, Maison P, Mazeron JJ, Cornu P, Delattre JY; Association des Neuro-Oncologues d'Expression Française (ANOCEF).

Brain. 2001 Dec;124(Pt 12):2528-39.

PMID:
11701605
8.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

9.

Diffuse Intrinsic Pontine Glioma: Time for Cautious Optimism.

Hennika T, Becher OJ.

J Child Neurol. 2016 Oct;31(12):1377-85. doi: 10.1177/0883073815601495. Epub 2015 Sep 14. Review.

10.

Brain stem tumors in children and adolescents: single institutional experience.

Garzón M, García-Fructuoso G, Guillén A, Suñol M, Mora J, Cruz O.

Childs Nerv Syst. 2013 Aug;29(8):1321-31. doi: 10.1007/s00381-013-2137-1. Epub 2013 May 12.

PMID:
23666431
11.

Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas.

Dorris K, Sobo M, Onar-Thomas A, Panditharatna E, Stevenson CB, Gardner SL, Dewire MD, Pierson CR, Olshefski R, Rempel SA, Goldman S, Miles L, Fouladi M, Drissi R.

J Neurooncol. 2014 Mar;117(1):67-76. doi: 10.1007/s11060-014-1374-9. Epub 2014 Jan 30. Erratum in: J Neurooncol. 2014 Aug;119(1):223-4.

12.

Adult brainstem gliomas.

Reyes-Botero G, Mokhtari K, Martin-Duverneuil N, Delattre JY, Laigle-Donadey F.

Oncologist. 2012;17(3):388-97. doi: 10.1634/theoncologist.2011-0335. Epub 2012 Mar 1. Review.

13.

Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy--results of a United Kingdom phase II trial (CNS 2007 04).

Bailey S, Howman A, Wheatley K, Wherton D, Boota N, Pizer B, Fisher D, Kearns P, Picton S, Saran F, Gibson M, Glaser A, Connolly DJ, Hargrave D.

Eur J Cancer. 2013 Dec;49(18):3856-62. doi: 10.1016/j.ejca.2013.08.006. Epub 2013 Sep 4.

14.

A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands.

Veldhuijzen van Zanten SE, Jansen MH, Sanchez Aliaga E, van Vuurden DG, Vandertop WP, Kaspers GJ.

Expert Rev Anticancer Ther. 2015 Feb;15(2):157-64. doi: 10.1586/14737140.2015.974563. Epub 2014 Nov 29.

PMID:
25435089
15.

Brainstem glioma: a review.

Grimm SA, Chamberlain MC.

Curr Neurol Neurosci Rep. 2013 May;13(5):346. doi: 10.1007/s11910-013-0346-3. Review.

PMID:
23512689
16.

Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma.

Carceller F, Fowkes LA, Khabra K, Moreno L, Saran F, Burford A, Mackay A, Jones DT, Hovestadt V, Marshall LV, Vaidya S, Mandeville H, Jerome N, Bridges LR, Laxton R, Al-Sarraj S, Pfister SM, Leach MO, Pearson AD, Jones C, Koh DM, Zacharoulis S.

J Neurooncol. 2016 Aug;129(1):109-21. doi: 10.1007/s11060-016-2151-8. Epub 2016 May 14.

PMID:
27180091
17.
18.

Histologically proven, low-grade brainstem gliomas in children: 30-year experience with long-term follow-up at Mayo Clinic.

Ahmed KA, Laack NN, Eckel LJ, Orme NM, Wetjen NM.

Am J Clin Oncol. 2014 Feb;37(1):51-6. doi: 10.1097/COC.0b013e31826b9903.

19.

6-year-old girl with hydrocephalus.

Chang HT, Cuison RV, Gera R, Saah E, Scott-Emuakpor A, Abood C.

Brain Pathol. 2009 Oct;19(4):725-6. doi: 10.1111/j.1750-3639.2009.00307.x.

PMID:
19744043
20.

A pediatric trial of radiation/cetuximab followed by irinotecan/cetuximab in newly diagnosed diffuse pontine gliomas and high-grade astrocytomas: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study.

Macy ME, Kieran MW, Chi SN, Cohen KJ, MacDonald TJ, Smith AA, Etzl MM, Kuei MC, Donson AM, Gore L, DiRenzo J, Trippett TM, Ostrovnaya I, Narendran A, Foreman NK, Dunkel IJ.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26621. Epub 2017 May 24.

PMID:
28544128

Supplemental Content

Support Center